US Stock MarketDetailed Quotes

RMD ResMed

Watchlist
  • 205.570
  • +2.420+1.19%
Trading Jul 22 10:57 ET
30.20BMarket Cap31.63P/E (TTM)

ResMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ResMed Earnings Date

Currency: USD

Period

Q4 FY2024 Estimates

Aug 1, 2024

Revenue(YoY)

1.21B

+8.21%
EPS(YoY)

1.99

+27.48%
Analyst Rating

Buy

Jul 22, 2024

ResMed Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.174B--
Aug 1, 20242024/Q4-- / 1.214B--
--2024/Q31.197B / 1.172B--
Jan 24, 20242024/Q21.163B / 1.151B--
Oct 26, 20232024/Q11.102B / 1.106B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.174B--
Aug 1, 20242024/Q4-- / 1.214B--
--2024/Q31.197B / 1.172B--
Jan 24, 20242024/Q21.163B / 1.151B--
Oct 26, 20232024/Q11.102B / 1.106B--

Unlock Free Earnings Estimates

ResMed Earnings Reports

  • 10-Q: Quarterly report

    Apr 26 15:59 ET

  • ResMed | 10-Q: Quarterly report

    Jan 25 15:36 ET

  • ResMed | 10-Q: Q1 2024 Earnings Report

    Oct 26, 2023 19:38 ET

  • ResMed | 10-K: FY2023 Annual Report

    Aug 10, 2023 20:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Buy

    • Buy

      70.00%

    • Hold

      30.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg